Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in Ewing sarcoma patients – associations with tumor phenotype and survival

BACKGROUND: Ewing sarcoma (ES) is driven by fusion of the EWS gene with an ETS transcription factor, most often FLI1. Neuropeptide Y (NPY) is an EWS-FLI1 transcriptional target. NPY is highly expressed in ES and exerts opposing effects, ranging from ES cell death to angiogenesis and cancer stem cell...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer
Prif Awduron: Tilan, Jason U., Krailo, Mark, Barkauskas, Donald A., Galli, Susana, Mtaweh, Haifa, Long, Jessica, Wang, Hongkun, Hawkins, Kirsten, Lu, Congyi, Jeha, Dima, Izycka-Swieszewska, Ewa, Lawlor, Elizabeth R., Toretsky, Jeffrey A., Kitlinska, Joanna
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4339539/
https://ncbi.nlm.nih.gov/pubmed/25387699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29090
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg